A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 75,100 shares of HCM stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,100
Previous 82,300 8.75%
Holding current value
$1.29 Million
Previous $1.49 Million 15.3%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$12.08 - $18.56 $86,976 - $133,632
-7,200 Reduced 8.75%
75,100 $1.26 Million
Q4 2023

Feb 13, 2024

BUY
$16.25 - $20.23 $492,375 - $612,969
30,300 Added 58.27%
82,300 $1.49 Million
Q3 2023

Nov 14, 2023

SELL
$11.85 - $16.95 $40,906 - $58,511
-3,452 Reduced 6.23%
52,000 $881,000
Q2 2023

Aug 11, 2023

SELL
$10.78 - $17.73 $1.01 Million - $1.66 Million
-93,800 Reduced 62.85%
55,452 $665,000
Q1 2023

May 12, 2023

BUY
$13.02 - $19.87 $777,294 - $1.19 Million
59,700 Added 66.67%
149,252 $1.94 Million
Q4 2022

Feb 13, 2023

SELL
$7.65 - $15.51 $18,360 - $37,224
-2,400 Reduced 2.61%
89,552 $1.32 Million
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $2.8 Million - $5.04 Million
-324,700 Reduced 77.93%
91,952 $815,000
Q2 2022

Aug 12, 2022

BUY
$8.59 - $20.77 $3.58 Million - $8.65 Million
416,652 New
416,652 $5.27 Million
Q1 2022

May 13, 2022

SELL
$15.52 - $35.65 $636,320 - $1.46 Million
-41,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$28.89 - $35.33 $2.96 Million - $3.62 Million
-102,352 Reduced 71.4%
41,000 $1.44 Million
Q3 2021

Nov 12, 2021

SELL
$35.66 - $42.94 $2.46 Million - $2.96 Million
-69,000 Reduced 32.49%
143,352 $5.25 Million
Q2 2021

Aug 13, 2021

SELL
$23.7 - $39.27 $215,670 - $357,357
-9,100 Reduced 4.11%
212,352 $8.34 Million
Q1 2021

May 13, 2021

SELL
$27.01 - $36.8 $1.52 Million - $2.06 Million
-56,100 Reduced 20.21%
221,452 $6.26 Million
Q4 2020

Feb 10, 2021

SELL
$27.51 - $34.36 $1.6 Million - $1.99 Million
-58,048 Reduced 17.3%
277,552 $8.89 Million
Q3 2020

Nov 13, 2020

SELL
$25.8 - $34.61 $1.71 Million - $2.29 Million
-66,200 Reduced 16.48%
335,600 $10.8 Million
Q2 2020

Aug 13, 2020

BUY
$17.65 - $28.05 $995,459 - $1.58 Million
56,400 Added 16.33%
401,800 $11.1 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $732,158 - $1.42 Million
48,200 Added 16.22%
345,400 $6.17 Million
Q4 2019

Feb 13, 2020

BUY
$17.17 - $25.95 $2.38 Million - $3.59 Million
138,400 Added 87.15%
297,200 $7.45 Million
Q3 2019

Nov 13, 2019

BUY
$17.84 - $22.69 $1.99 Million - $2.53 Million
111,400 Added 235.02%
158,800 $2.83 Million
Q2 2019

Aug 12, 2019

BUY
$22.0 - $31.78 $81,400 - $117,586
3,700 Added 8.47%
47,400 $1.04 Million
Q1 2019

May 14, 2019

SELL
$21.27 - $30.58 $697,656 - $1 Million
-32,800 Reduced 42.88%
43,700 $1.34 Million
Q4 2018

Feb 13, 2019

BUY
$23.09 - $37.69 $1.77 Million - $2.88 Million
76,500 New
76,500 $1.77 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.96B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.